Related references
Note: Only part of the references are listed.The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence
Roger S. McIntyre et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
Nolan R. Williams et al.
MOLECULAR PSYCHIATRY (2019)
Pharmacotherapy for dissociative disorders: A systematic review
Roshan Sutar et al.
PSYCHIATRY RESEARCH (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
Mark J. Niciu et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: Analysis of the Clinician Administered Dissociative State Scale
Gerrit I. van Schalkwyk et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
Cristina Cusin et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review
Matthew D. Cooper et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2017)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
David Feifel et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion
Steven J. Pennybaker et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Gerard Sanacora et al.
JAMA PSYCHIATRY (2017)
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
Jaskaran B. Singh et al.
BIOLOGICAL PSYCHIATRY (2016)
The use of ketamine as an antidepressant: a systematic review and meta-analysis
Caoimhe M. Coyle et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
Concomitant Benzodiazepine Use Attenuates Ketamine Response
Mark A. Frye et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
Le-Ben Wan et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A. Luckenbaugh et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Dissociative Disorders in DSM-5
David Spiegel et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 9 (2013)
Share Paper
